Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (253)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type
Tucatinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Tucatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Tucidinostat	HDAC Inhibitor	Hematologic (Lymphoma)
Molecule Tucidinostat Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Tuvusertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Tuvusertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Ulixertinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Ulixertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Umbralisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Umbralisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Uprosertib	AKT Inhibitor	Solid Tumour
Molecule Uprosertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Valemetostat	EZH2 / Menin Inhibitor	Hematologic
Molecule Valemetostat Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Vandetanib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Vandetanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Varlitinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Varlitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Vatalanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Vatalanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Vecabrutinib	BTK Inhibitor	Hematologic (Lymphoma/CLL)
Molecule Vecabrutinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma/CLL) Drug Class / Mechanism BTK Inhibitor
Veliparib	PARP Inhibitor	Solid Tumour
Molecule Veliparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor

Tucatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Tucidinostat Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Tuvusertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Ulixertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Umbralisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor
Uprosertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Valemetostat Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Vandetanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Varlitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Vatalanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Vecabrutinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma/CLL) Drug Class / Mechanism BTK Inhibitor
Veliparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor

‹ 1 … 18 19 20 21 22 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (253)

Tucatinib

Tucidinostat

Tuvusertib

Ulixertinib

Umbralisib

Uprosertib

Valemetostat

Vandetanib

Varlitinib

Vatalanib

Vecabrutinib

Veliparib

Tucatinib

Tucidinostat

Tuvusertib

Ulixertinib

Umbralisib

Uprosertib

Valemetostat

Vandetanib

Varlitinib

Vatalanib

Vecabrutinib

Veliparib